---
title: "亚虹医药-U (688176.SH) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/688176.SH/norm.md"
symbol: "688176.SH"
name: "亚虹医药-U"
parent: "https://longbridge.com/zh-CN/quote/688176.SH.md"
datetime: "2026-03-09T14:43:51.408Z"
locales:
  - [en](https://longbridge.com/en/quote/688176.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688176.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688176.SH/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/688176.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688176.SH/norm.md)


# 亚虹医药-U (688176.SH) — 财务报表

## 利润表 (CNY)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3161 | -0.1499 | -0.1400 | -0.1500 | -0.1999 |
| ROE | -39.07% | -19.47% | -16.97% | -17.31% | -22.38% |
| 营业收入 | 60.71M | 86.17M | 69.14M | 61.10M | 62.61M |
| 净利润 | -170.39M | -86.73M | -78.68M | -83.53M | -113.22M |
| 营业利润 | -159.14M | -92.52M | -89.49M | -90.15M | -125.13M |
| 毛利率 | 189.98% | 77.13% | 68.16% | 78.87% | 65.27% |
| 净利率 | -280.65% | -100.65% | -113.81% | -136.71% | -180.84% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (CNY)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | - | 2.15B | 2.17B | 2.16B | 2.22B |
| 权益乘数 | - | 1.24 | 1.20 | 1.14 | 1.13 |
| 每股净资产 | - | 3.10 | 3.24 | 3.37 | 3.51 |
| 资产周转率 | - | 0.1250 | 0.1088 | 0.1010 | 0.0830 |
| 现金及短投 | - | 1.69B | 1.73B | 1.67B | 1.44B |
| 存货与应收 | - | 11.74M | 9.74M | 7.16M | 5.84M |
| 长期投资 | - | 72.24M | 74.50M | 79.80M | 85.45M |
| 净债务 | - | -1.37B | -1.47B | -1.50B | -1.31B |

## 现金流量表 (CNY)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | -107.53M | -83.91M | -110.36M | -99.79M |
| 投资现金流 | - | -20.42M | -359.44M | 319.56M | 353.49M |
| 融资现金流 | - | 60.14M | 85.23M | 35.72M | -7.65M |
| 自由现金流 | - | -126.88M | -40.45M | -92.75M | -18.64M |
| 现金流充裕率 | - | 522283.47% | -436.85% | -297.03% | -202.50% |
| 举债与偿债 | - | 63.74M | 90.26M | 77.29M | 29.70M |
| 资本支出 | - | -3.11M | -9.43M | -228607.00 | -1.98M |